Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Webcast
1 AMA PRA Category 1 Credit™ ...OVERVIEW
Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management is organized by Med Learning Group.
Released Date: July 17, 2024
Expiration Date: July 17, 2025
Description:
This educational activity is designed to provide clinicians who manage patients with Alzheimer’s disease with current information on diagnosis and management, including the impact of the disease on caregivers.
Learning Objectives:
Upon the completion of this program, attendees should be able to:
- Implement shared decision-making (SDM) approaches to facilitate diagnosis and optimize management
- Implement strategies to overcome barriers to timely diagnosis of Alzheimer’s disease, addressing stigma, applying quantitative assessments, and integrating neuroimaging as well as specialty referral in clinical assessment.
ACCREDITATION & CREDITS
Accreditation:
Joint Accreditation Statement:
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement:
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.
Nurses (ANCC) Credit Designation:
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.
TARGET AUDIENCE
PhysicianNursesGeriatricsHealthcare ProvidersPsychiatristsPrimary Care PhysiciansSPECIALITIES
NeurologyPatient and Family Centered Care
Quick Links